Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
about
Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placeboDuctal approaches to assessment and management of women at high risk for developing breast cancerIn vivo cell kinetics in breast carcinogenesisThe utility of ductal lavage in breast cancer detection and risk assessmentThe diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classificationTowards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormonesCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemBreast cancer risk accumulation starts early: prevention must alsoBreast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Aromatase expression in atypical ductal hyperplasia in women.Management of breast fibroadenomas.Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesionsProtein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.Pathogenesis, prevention, diagnosis and treatment of breast cancer.Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasiaThe importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical Excision Obviated?Understanding mathematical models for breast cancer risk assessment and counseling.Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.Who's liable for breast cancer prevention? Your patient can sue--and win--if preventive options aren't made clear.Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary.Assessment of DNA methylation status in early stages of breast cancer development.Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial contentLinks between alcohol consumption and breast cancer: a look at the evidenceThe intraductal approach to the breast: raison d'être.The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.Ductal lavage for breast cancer risk assessment.A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008.Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.A multistage association study identifies a breast cancer genetic locus at NCOA7.Model for individualized prediction of breast cancer risk after a benign breast biopsy.Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast CancerDoes histopathological examination of breast reduction specimens affect patient management and clinical follow up?Benign breast lesions in Bayelsa State, Niger Delta Nigeria: a 5 year multicentre histopathological audit.Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care populationNuclear morphometry in columnar cell lesions of the breast: is it useful?Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.
P2860
Q21261269-70EE6629-F289-4D9A-876B-56BAF4909ABCQ24794407-DF3C029D-898E-4D85-806F-388BF7E3FBB6Q24800580-842A1E03-8B0D-4FCE-8121-A0E4165C0186Q24802209-8F43C9AD-C2DC-4FE0-A470-301EB64E9468Q24803360-74C92DC8-38CC-47E9-8898-542DB6832BB5Q24806501-A0F7C703-343F-4DCD-A04E-A893FAA3FD6FQ26748510-CA0C92E2-02F1-4316-8956-E3A817B4074FQ26851902-8188277D-EF0D-49FD-8E27-C3DDEE46912FQ30248838-506350F8-BA9A-4FBA-8667-A5ADCAB9B7E8Q30252881-99520BAF-5840-447B-89E8-DED2E12BB098Q30499532-689D2E06-42A5-4DBE-BB1B-5E02501DEFC4Q33562282-A2523432-C939-45A7-8DC6-AA3AC4A4B7C2Q33596201-7F93F0B4-7DE3-40B4-91E1-76D7CE593A94Q33623768-87BBF43C-01D7-4373-9907-A7C227B5C654Q33862910-D601159B-7556-42CA-8FB2-BEDCE186D358Q34023647-BEEC637D-DAA1-450C-B777-A77BE90D5A60Q34049245-CDFD4D17-BE25-424A-BAA1-C630AEFD3A88Q34103339-97163B3F-76EC-4E61-A7D6-961AB1C8D417Q34340627-F78BE55F-9E2C-463F-98AA-4CB002D2C7DDQ34419051-71C3F625-D660-4C43-B86F-B7E6F542BEF4Q34480678-C778AB58-84A0-47DA-8CFC-E7496F090E0AQ34545706-3D5163B9-791F-4AB9-99FE-7D57000D3A04Q34568124-67AFA244-AD96-4D9A-BFBA-7FDD0E3FDBAAQ34709370-186F00B0-8465-4305-B440-0524FFF38E27Q34712100-A8B36897-F8C6-4FAA-83E7-F68D61AE1403Q34987627-ABE06409-6CA7-48C7-90E0-E821449E5506Q35012715-CF4D3B92-7F29-4182-B71C-747828F490F7Q35038233-7C499C12-7AD3-49F4-9371-83ECB1A7E000Q35039485-16A2958F-B6EA-4A09-89AF-670E533E760FQ35053869-86388201-C5D7-4F8C-9D48-76A918095DAAQ35064661-810C5A06-2203-4E02-B99F-608DA6258658Q35108072-73A0C287-84B1-4142-A0A8-68F2983CA7D4Q35144259-DC205096-36FF-47BF-9396-0A47A97DDA5DQ35193877-9F40304F-7CEF-4CAE-B405-DD9A12E3CE1EQ35431358-5E2CD192-0351-4336-900D-EC597B28A2C4Q35587486-AC822653-AFCD-4B0C-AED0-B9AE66941EBFQ35601816-842E4329-6D85-4CA6-AE98-16C527DB4662Q35688411-390A3B37-3DB6-4BB1-BB28-04502397A6A6Q35770437-9CA51A23-FAD3-4209-8116-ACE4922FA349Q35846896-34A1ED7E-9477-4514-A837-A5141D6D595C
P2860
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
@en
type
label
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
@en
prefLabel
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
@en
P2093
P1433
P1476
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
@en
P2093
Hartmann WH
Plummer WD
Schuyler PA
Winfield AC
Worrell JA
P304
P356
10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I
P407
P577
1993-02-01T00:00:00Z